Hydroxychloroquine in systemic lupus erythematosus, anti-SSA/SSB, and antiphospholipid antibody-positive pregnancies

Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloro...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of obstetrics and gynecology
Main Authors:	Saleh, Zeinab F., Somers, Emily C., Romero, Vivian C., Marder, Wendy
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 08.09.2025
Subjects:	adverse pregnancy outcomes antiphospholipid syndrome autoimmune rheumatic diseases congenital malformations hydroxychloroquine Obstetrics and Gynecology SSA/SSB positive systemic lupus erythematosus teratogenicity antiphospholipid syndrome systemic lupus erythematosus adverse pregnancy outcomes hydroxychloroquine autoimmune rheumatic diseases congenital malformations teratogenicity SSA/SSB positive
ISSN:	0002-9378, 1097-6868, 1097-6868
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!